Global Bio Simulation Market Research Report 2024

Publication ID:

PB504247815

Publication Date:

April 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Biosimulation is computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology.
The global Bio Simulation market was valued at US$ 1067 million in 2023 and is anticipated to reach US$ 2926.1 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
North American market for Bio Simulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio Simulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Bio Simulation in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Bio Simulation include Altair Engineering Inc., ANSYS Inc., Certara LP, Dassault Systemes SE, Genedata AG, Intelligen Inc., Physiomics Plc, PPD Inc. and Schrodinger Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio Simulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Simulation.
Report Scope
The Bio Simulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio Simulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Simulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Altair Engineering Inc.
ANSYS Inc.
Certara LP
Dassault Systemes SE
Genedata AG
Intelligen Inc.
Physiomics Plc
PPD Inc.
Schrodinger Inc.
Simulations Plus Inc.
Rhenovia Pharma
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Segment by Type
Software
Services
Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio Simulation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Simulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Services
1.3 Market by Application
1.3.1 Global Bio Simulation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Contract Research Organizations
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio Simulation Market Perspective (2019-2030)
2.2 Bio Simulation Growth Trends by Region
2.2.1 Global Bio Simulation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio Simulation Historic Market Size by Region (2019-2024)
2.2.3 Bio Simulation Forecasted Market Size by Region (2025-2030)
2.3 Bio Simulation Market Dynamics
2.3.1 Bio Simulation Industry Trends
2.3.2 Bio Simulation Market Drivers
2.3.3 Bio Simulation Market Challenges
2.3.4 Bio Simulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio Simulation Players by Revenue
3.1.1 Global Top Bio Simulation Players by Revenue (2019-2024)
3.1.2 Global Bio Simulation Revenue Market Share by Players (2019-2024)
3.2 Global Bio Simulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bio Simulation Revenue
3.4 Global Bio Simulation Market Concentration Ratio
3.4.1 Global Bio Simulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Simulation Revenue in 2023
3.5 Bio Simulation Key Players Head office and Area Served
3.6 Key Players Bio Simulation Product Solution and Service
3.7 Date of Enter into Bio Simulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Simulation Breakdown Data by Type
4.1 Global Bio Simulation Historic Market Size by Type (2019-2024)
4.2 Global Bio Simulation Forecasted Market Size by Type (2025-2030)
5 Bio Simulation Breakdown Data by Application
5.1 Global Bio Simulation Historic Market Size by Application (2019-2024)
5.2 Global Bio Simulation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bio Simulation Market Size (2019-2030)
6.2 North America Bio Simulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bio Simulation Market Size by Country (2019-2024)
6.4 North America Bio Simulation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio Simulation Market Size (2019-2030)
7.2 Europe Bio Simulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bio Simulation Market Size by Country (2019-2024)
7.4 Europe Bio Simulation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio Simulation Market Size (2019-2030)
8.2 Asia-Pacific Bio Simulation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bio Simulation Market Size by Region (2019-2024)
8.4 Asia-Pacific Bio Simulation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio Simulation Market Size (2019-2030)
9.2 Latin America Bio Simulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bio Simulation Market Size by Country (2019-2024)
9.4 Latin America Bio Simulation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio Simulation Market Size (2019-2030)
10.2 Middle East & Africa Bio Simulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bio Simulation Market Size by Country (2019-2024)
10.4 Middle East & Africa Bio Simulation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Altair Engineering Inc.
11.1.1 Altair Engineering Inc. Company Detail
11.1.2 Altair Engineering Inc. Business Overview
11.1.3 Altair Engineering Inc. Bio Simulation Introduction
11.1.4 Altair Engineering Inc. Revenue in Bio Simulation Business (2019-2024)
11.1.5 Altair Engineering Inc. Recent Development
11.2 ANSYS Inc.
11.2.1 ANSYS Inc. Company Detail
11.2.2 ANSYS Inc. Business Overview
11.2.3 ANSYS Inc. Bio Simulation Introduction
11.2.4 ANSYS Inc. Revenue in Bio Simulation Business (2019-2024)
11.2.5 ANSYS Inc. Recent Development
11.3 Certara LP
11.3.1 Certara LP Company Detail
11.3.2 Certara LP Business Overview
11.3.3 Certara LP Bio Simulation Introduction
11.3.4 Certara LP Revenue in Bio Simulation Business (2019-2024)
11.3.5 Certara LP Recent Development
11.4 Dassault Systemes SE
11.4.1 Dassault Systemes SE Company Detail
11.4.2 Dassault Systemes SE Business Overview
11.4.3 Dassault Systemes SE Bio Simulation Introduction
11.4.4 Dassault Systemes SE Revenue in Bio Simulation Business (2019-2024)
11.4.5 Dassault Systemes SE Recent Development
11.5 Genedata AG
11.5.1 Genedata AG Company Detail
11.5.2 Genedata AG Business Overview
11.5.3 Genedata AG Bio Simulation Introduction
11.5.4 Genedata AG Revenue in Bio Simulation Business (2019-2024)
11.5.5 Genedata AG Recent Development
11.6 Intelligen Inc.
11.6.1 Intelligen Inc. Company Detail
11.6.2 Intelligen Inc. Business Overview
11.6.3 Intelligen Inc. Bio Simulation Introduction
11.6.4 Intelligen Inc. Revenue in Bio Simulation Business (2019-2024)
11.6.5 Intelligen Inc. Recent Development
11.7 Physiomics Plc
11.7.1 Physiomics Plc Company Detail
11.7.2 Physiomics Plc Business Overview
11.7.3 Physiomics Plc Bio Simulation Introduction
11.7.4 Physiomics Plc Revenue in Bio Simulation Business (2019-2024)
11.7.5 Physiomics Plc Recent Development
11.8 PPD Inc.
11.8.1 PPD Inc. Company Detail
11.8.2 PPD Inc. Business Overview
11.8.3 PPD Inc. Bio Simulation Introduction
11.8.4 PPD Inc. Revenue in Bio Simulation Business (2019-2024)
11.8.5 PPD Inc. Recent Development
11.9 Schrodinger Inc.
11.9.1 Schrodinger Inc. Company Detail
11.9.2 Schrodinger Inc. Business Overview
11.9.3 Schrodinger Inc. Bio Simulation Introduction
11.9.4 Schrodinger Inc. Revenue in Bio Simulation Business (2019-2024)
11.9.5 Schrodinger Inc. Recent Development
11.10 Simulations Plus Inc.
11.10.1 Simulations Plus Inc. Company Detail
11.10.2 Simulations Plus Inc. Business Overview
11.10.3 Simulations Plus Inc. Bio Simulation Introduction
11.10.4 Simulations Plus Inc. Revenue in Bio Simulation Business (2019-2024)
11.10.5 Simulations Plus Inc. Recent Development
11.11 Rhenovia Pharma
11.11.1 Rhenovia Pharma Company Detail
11.11.2 Rhenovia Pharma Business Overview
11.11.3 Rhenovia Pharma Bio Simulation Introduction
11.11.4 Rhenovia Pharma Revenue in Bio Simulation Business (2019-2024)
11.11.5 Rhenovia Pharma Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic Bio Simulation Introduction
11.12.4 Medtronic Revenue in Bio Simulation Business (2019-2024)
11.12.5 Medtronic Recent Development
11.13 Advanced Chemistry Development
11.13.1 Advanced Chemistry Development Company Detail
11.13.2 Advanced Chemistry Development Business Overview
11.13.3 Advanced Chemistry Development Bio Simulation Introduction
11.13.4 Advanced Chemistry Development Revenue in Bio Simulation Business (2019-2024)
11.13.5 Advanced Chemistry Development Recent Development
11.14 Chemical Computing Group
11.14.1 Chemical Computing Group Company Detail
11.14.2 Chemical Computing Group Business Overview
11.14.3 Chemical Computing Group Bio Simulation Introduction
11.14.4 Chemical Computing Group Revenue in Bio Simulation Business (2019-2024)
11.14.5 Chemical Computing Group Recent Development
11.15 Entelos Holding Corporation
11.15.1 Entelos Holding Corporation Company Detail
11.15.2 Entelos Holding Corporation Business Overview
11.15.3 Entelos Holding Corporation Bio Simulation Introduction
11.15.4 Entelos Holding Corporation Revenue in Bio Simulation Business (2019-2024)
11.15.5 Entelos Holding Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Altair Engineering Inc.
ANSYS Inc.
Certara LP
Dassault Systemes SE
Genedata AG
Intelligen Inc.
Physiomics Plc
PPD Inc.
Schrodinger Inc.
Simulations Plus Inc.
Rhenovia Pharma
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂